These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 22198502

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.
    Cowan CM, Fan MM, Fan J, Shehadeh J, Zhang LY, Graham RK, Hayden MR, Raymond LA.
    J Neurosci; 2008 Nov 26; 28(48):12725-35. PubMed ID: 19036965
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.
    Shehadeh J, Fernandes HB, Zeron Mullins MM, Graham RK, Leavitt BR, Hayden MR, Raymond LA.
    Neurobiol Dis; 2006 Feb 26; 21(2):392-403. PubMed ID: 16165367
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.
    Fan MM, Fernandes HB, Zhang LY, Hayden MR, Raymond LA.
    J Neurosci; 2007 Apr 04; 27(14):3768-79. PubMed ID: 17409241
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
    Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA.
    Neuron; 2002 Mar 14; 33(6):849-60. PubMed ID: 11906693
    [Abstract] [Full Text] [Related]

  • 14. Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin.
    Parsons MP, Kang R, Buren C, Dau A, Southwell AL, Doty CN, Sanders SS, Hayden MR, Raymond LA.
    J Biol Chem; 2014 Feb 07; 289(6):3518-28. PubMed ID: 24347167
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression.
    Martel MA, Soriano FX, Baxter P, Rickman C, Duncan R, Wyllie DJ, Hardingham GE.
    Channels (Austin); 2009 Feb 07; 3(1):12-5. PubMed ID: 19221512
    [Abstract] [Full Text] [Related]

  • 17. Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.
    Li L, Murphy TH, Hayden MR, Raymond LA.
    J Neurophysiol; 2004 Nov 07; 92(5):2738-46. PubMed ID: 15240759
    [Abstract] [Full Text] [Related]

  • 18. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
    Fan J, Vasuta OC, Zhang LY, Wang L, George A, Raymond LA.
    J Neurochem; 2010 Nov 07; 115(4):1045-56. PubMed ID: 20831617
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.
    Zeron MM, Fernandes HB, Krebs C, Shehadeh J, Wellington CL, Leavitt BR, Baimbridge KG, Hayden MR, Raymond LA.
    Mol Cell Neurosci; 2004 Mar 07; 25(3):469-79. PubMed ID: 15033175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.